Powder: -20°C for 3 years | In solvent: -80°C for 1 year
WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3. This compound binds JAK3 weakly and may be used as a JAK-binding negative control in the development of new therapeutics.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 51.00 | |
10 mg | In stock | $ 80.00 | |
25 mg | In stock | $ 155.00 | |
50 mg | In stock | $ 249.00 | |
100 mg | In stock | $ 419.00 | |
500 mg | In stock | $ 957.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 57.00 |
Description | WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3. This compound binds JAK3 weakly and may be used as a JAK-binding negative control in the development of new therapeutics. |
Targets&IC50 | JAK3:72 μM(Ki) |
Molecular Weight | 281.31 |
Formula | C16H15N3O2 |
CAS No. | 21561-09-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 6 mg/mL (21.33 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
WHI-P258 21561-09-1 Angiogenesis Chromatin/Epigenetic JAK/STAT signaling MAPK Stem Cells Tyrosine Kinase/Adaptors EGFR JAK JNK WHI P258 WHI-P 258 inhibit WHI-P-258 Inhibitor WHIP258 inhibitor